School of Biomedical Sciences
Tony Bjourson was born in Strabane, Co Tyrone in Northern Ireland. He was appointed Director of the Biomedical Sciences Research Institute (BMSRI) at Ulster University in late 2007. He obtained his MSc in Biological Sciences from Ulster University and his PhD from Queen’s University Belfast. He has over 28 years of research experience in a diverse range of molecular biological/genomic projects and he has published extensively in peer-reviewed molecular biology journals. Prior to joining Ulster in 2001, he established and managed genomic programmes for the DARDNI and Queens University Belfast and participated in the first ever international eukaryotic genome project (EU Yeast Genome sequencing program 1994-1996). In the early 1990’s he developed novel subtraction hybridisation technologies that were subsequently used for the identification of specific nucleic acid sequences in a diverse range of cell types. After joining Ulster he led the Pharmaceutical Biotechnology Research Group and subsequently established and led the Biomedical Genomics Research Group. He also managed the Genomics Unit within the Centre for Molecular Biosciences (CMB). He has considerable experience of managing both large research infrastructure projects, focused basic research projects, and overseeing delivery of associated objectives.
His current research is focused on genomics based personalised medicine in the area of cancer and autoimmune disease and pharmacogenomic.
The association of monocytes and Tregs with disease activity in rheumatoid arthritis The Journal of Immunology Date: (2017)
Coincidence versus consequence: opportunities in multi-morbidity research and inflammation as a pervasive feature Expert Review of Precision Medicine and Drug Development Date: (2017)
Metabolic and neuroprotective effects of dapagliflozin and liraglutide in diabetic mice Journal of Endocrinology Date: (2017)